In This Article:
NEW YORK, Jan. 17, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in minimally invasive Microwave Ablation (MWA) technology, was present in San Francisco amid the 2025 J.P. Morgan Healthcare Conference, one of the most prominent healthcare investment gatherings globally.
Following its successful debut on Nasdaq in October 2024, Baird Medical connected with healthcare investors and industry leaders during the week of the conference, engaging in meaningful discussions on the company's advancements in microwave ablation technology and its commitment to improving patient outcomes.
"Being in San Francisco during the J.P. Morgan Healthcare Conference provided a valuable opportunity to engage with shareholders, innovators, and advisors in the healthcare sector," said Haimei Wu, Chairwoman of Baird Medical. "These discussions allowed us to share our vision for growth and innovation in the years ahead."
Looking ahead, Baird Medical remains committed to leveraging the insights and relationships gained from these interactions to drive its 2025 strategic initiatives. The company will continue expanding its U.S. footprint and collaborating with key opinion leaders (KOLs) who share its mission of enhancing patient care through cutting-edge medical technology.
About Baird Medical
Baird Medical is a leading provider of minimally invasive microwave ablation (MWA) technology, offering advanced treatment solutions for conditions such as thyroid nodules, breast disease, uterine fibroids, and liver cancer. A publicly traded company on NASDAQ, Baird Medical is dedicated to enhancing patient care through precision, efficiency, and safety in its innovative medical devices. For more information, please visit https://bairdmed.com/
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not historical facts and generally relate to future events or Baird Medical's future financial or operational performance. In some cases, you can identify forward-looking statements by terminology such as "may," "might," "will," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue," or the negative of these terms or other similar expressions.